November 11, 2014
ISTO Technologies to Present at 2014 Stifel Healthcare Conference
November 10, 2014
MiMedx (MDXG) appoints EVP
November 7, 2014
MiMedx (MDXG) Adds EVP and CCO executive
November 6, 2014
Thursday’s RegMed rhythms, sector bloodbath is fugly– carnage increase spillage
November 6, 2014
bluebird bio (BLUE): LentiGlobin clinical data at ASH meeting 12/6-12/9
November 4, 2014
Lower open expected; RegMed will flip slowly from the slip
October 30, 2014
Thursday’s RegMed rhythms – pennies versus dollars
October 27, 2014
Monday’s RegMed rhythms – weak on low volume
October 21, 2014
Tuesday’s RegMed rhythms – Transparency needs to be more transcendent!
October 21, 2014
ISTO Technologies to present at 12th Annual 2014 Musculoskeletal New Ventures Conference
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.